Latest News and Press Releases

9 January 2018Midatech Pharma PLC("Midatech" or the "Company") Midatech receives confirmation that its Q-Octreotide (MTD201) first in-human EU study is approved Midatech (AIM: MTPH,...

  2 January 2018Midatech Pharma PLC("Midatech" or the "Company") Midatech enters into a Loan Agreement with MidCap Financial Midatech (AIM: MTPH, Nasdaq: MTP), the international...

Midatech Pharma PLC("Midatech" or the "Company") Midatech Pharma US initiates Gelclair® Phase IV trial to study oral mucositis in stem cell transplant patients Trial to be conducted at the...

4 September 2017Midatech Pharma PLC("Midatech", "Company" or "Group") Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly Midatech on track to start...

26 July 2017Midatech Pharma PLC("Midatech", "Company" or "Group") Completion of pre-clinical liver cancer programme Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty...

18 July 2017Midatech Pharma PLC("Midatech", "Company" or "Group") Trading Update and Notice of Results Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical...

Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products in oncology, is hosting a site visit today at its...

Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products in oncology, today announces that it has signed a global...

Midatech Announces Successful Initial Scale-Up of Its Sustained Release Manufacturing Facility ~ Q-Octreotide will become Midatech's first Sustained Release product candidate manufactured in house at...

Midatech Pharma PLC("Midatech", "Company" or "Group")  Trading Update Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and...